Portuguese Prime Minister Visits Botton-Champalimaud Pancreatic Cancer Centre

LISBON, PORTUGAL - SEPTEMBER 03: The Portuguese Prime Minister Luis Montenegro and the President of the Champalimaud Foundation Leonor Beleza are seen through a Siemens Healthineers equipment during the PM visit to Botton-Champalimaud Pancreatic Cancer Centre on September 03, 2024, in Lisbon, Portugal. Champalimaud Foundation states that the Botton-Champalimaud Pancreatic Cancer Centre, resulting from a partnership between the Champalimaud Foundation and Mauricio and Charlotte Botton, is the first in the world simultaneously dedicated to the research and treatment of pancreatic cancer, one of the deadliest types of cancer. Combining state of the art services and equipment, aimed at guaranteeing the well-being and comfort of patients, supported by the most advanced techniques, and resulting from an exclusive aesthetic approach, this center comprises areas of research laboratories, a day hospital, a surgical centre, as well as inpatient and intensive care facilities. Over the past 20 years, the number of people with pancreatic cancer has increased exponentially throughout most of the world, especially in the most industrialized countries, and it is already the fourth leading cause of cancer death in Europe. The new Botton-Champalimaud Pancreatic Cancer Centre is a clear response to the need for targeted action towards better knowledge and control of a disease that, in 80% of cases, is diagnosed at an advanced stage and, therefore, is one of the most lethal. This Centre continues the innovative and distinguishing model initiated at the Champalimaud Foundation in 2010 - bringing science, clinic and patients closer together - adopting a translational methodology, which establishes a direct and interdependent relationship between research and clinical activity. (Photo by Horacio Villalobos#Corbis/Corbis via Getty Images)